Skip to main content
S&P 5007,623.68-0.52%DOW52,215.16-1.23%NASDAQ25,955.34-0.21%BTC$80,645.00-0.98%ETH$2,373.55-0.82%GOLD$4,010.00-1.24%OIL$103.44+3.99%
Smart Investors Daily
SID Premium
PA

NASDAQ · PACB

Pacific Biosciences of California, Inc.

Healthcare · Medical - Devices

$2.11

Up+$0.05 (+2.43%)

Updated Oct 25, 2026, 1:08 AM

SID Score

5.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
652.12M
P/E ratio
-1.29
Dividend yield
0.00%
52-week range
$1.07 – $3.44
Volume
5.72M
Avg. volume
9M

Price performance · PACB

PACB price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 23, 2026

PACB closed at $2.11 after 20 trading sessions, up 23.39% for the selected period.

Last close
$2.11
Period change
+23.39%
Period low
$1.71
Period high
$2.87
Daily close
View OHLC price history
PACB OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 23, 2026$2.02$2.13$1.97$2.115.72M
Oct 22, 2026$2.13$2.21$2.05$2.069.18M
Oct 21, 2026$1.965$2.1891$1.92$2.1413.5M
Oct 20, 2026$1.815$2.06$1.7601$1.9610.36M
Oct 19, 2026$1.78$1.86$1.74$1.846.04M
Oct 16, 2026$1.96$1.96$1.70$1.7310.43M
Oct 15, 2026$1.93$2.00$1.86$1.9612.62M
Oct 14, 2026$2.00$2.08$1.945$1.999.21M
Oct 13, 2026$2.07$2.1369$1.99$2.0512.29M
Oct 12, 2026$2.24$2.2859$2.01$2.1012.08M
Oct 9, 2026$2.36$2.47$2.21$2.3312.82M
Oct 8, 2026$2.63$2.69$2.22$2.3024.14M
Oct 7, 2026$2.62$2.74$2.50$2.7220.37M
Oct 6, 2026$3.015$3.435$2.4331$2.7047.11M
Oct 5, 2026$2.53$2.92$2.51$2.8726.25M
Oct 2, 2026$2.50$2.645$2.44$2.5426.01M
Oct 1, 2026$2.34$2.555$2.32$2.5135.87M
Sep 30, 2026$1.84$2.455$1.84$2.3780.39M
Sep 29, 2026$1.68$1.85$1.63$1.8317.42M
Sep 28, 2026$1.60$1.80$1.59$1.7121.28M

Latest PACB news

The latest Smart Investors Daily articles mentioning PACB.

Stock researchCompany · Overview

PACB research

Overview

Company profile and research snapshot.

Company profile

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$1.60
Implied upside
—
Analysts
—
PACB recent ratings
DateFirmRatingTarget
May 11, 2026BarclaysUnderweight—
Apr 14, 2026BarclaysUnderweight—
Mar 6, 2026BarclaysUnderweight—
Dec 15, 2025BarclaysEqual-Weight—
Nov 11, 2025Piper SandlerNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 19, 2026

PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI

Verily Pre will connect PacBio HiFi Sequencing with governed cloud analysis, multimodal health data and AI-ready research workflowsMENLO PARK, Calif. and DALLAS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Verily Health Inc., a healthcare data intelligence company, announced today a multi-year strategic collaboration to integrate PacBio HiFi sequencing with Verily Health’s governed data and AI platform. The collabor

Yahoo · Oct 14, 2026

PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026

MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2026 financial results on Wednesday, November 4, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). The call will be webcast and may be accessed on PacBio’s website at https://investor.pacificbiosciences.com/. Date: Wednesday, November 4, 2026, at 4:30 p.m. ET (1:30 p.m. PT) Listen live via internet or replay: https://inve

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By